Gland Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. Such certificates are typically filed periodically by listed companies through their Registrar and Share Transfer Agent (RTA) to confirm compliance with depository-related requirements, including maintenance of records and share-related activities. The filing appears to be a routine regulatory submission and does not disclose any specific financial figures, corporate action, or material event. No details on the certifying authority or the exact period covered were mentioned in the headline.
This is a routine compliance filing with no material impact on the company's operations, financials, or share price. Retail investors need not take any action based on this disclosure.